Picture BIO Deutschland Corona Special Germany 2020 650x80px

Document › Details

MolMed S.p.A. (at the request of AGC Inc.). (4/2/20). "Press Release: Offer Document Filed with Consob. Voluntary Public Tender Offer Launched by AGC Inc. on All the Ordinary Shares of MolMed S.p.A. [Not for release where violation of laws or regulations

	Organisation	AGC Inc. (JP)
	Group	Asahi Glass (AGC) (Group)
	Organisation 2	MolMed S.p.A. (MLMD.MI)
	Group	Asahi Glass (AGC) (Group)
	Product	contract manufacturing (biologicals)
	Product 2	cell therapy manufacturing/processing technology
	Index term	MolMed–Asahi Glass: investment, 202003– cash tender offer €240m for 463.5m shares at €0.518/share by AGC Inc ANNOUNCED

Original document
accessed by [iito] on 2020-04-14

Record changed: 2020-04-20

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

More documents for Asahi Glass (AGC) (Group)

[1] MolMed S.p.A.. (4/14/20). "Press Release: MolMed: the Board of Directors, Based on the Scientific Evidence from the Experiments on Early-stage Pre-clinical Products, Decided to Suspend the Investments in These Projects". Milan....
[2] AGC Inc.. (3/17/20). "Press Release: AGC Decides to Launch Voluntary Tender Offer for Shares of MolMed"....
[3] MolMed S.p.A.. (3/9/20). "Press Release: The Board of Directors Approved the 2019 Full Year Financial Results". Milan....
[4] MolMed S.p.A.. (3/6/20). "Press Release: MolMed Signs a Multi-year Agreement and Announces the Beginning of a New Collaboration in the Field of T Cell Therapies". Milan....
[5] MolMed S.p.A.. (12/18/19). "Press Release: Italy – the EIB Supports MolMed Investment in Research, Development and Manufacturing for Cancer and Rare Diseases Innovative Treatments". Oxford....
[6] MolMed S.p.A.. (10/10/19). "Press Release: MolMed Informs on Its Decision to Withdraw the Conditional Marketing Authorization of Zalmoxis". Milan....
[7] MolMed S.p.A.. (3/13/19). "Press Release: Partnership in the Field of Rare Genetic Diseases with Rocket Pharma Extended to Three New Therapeutic Indications". Milan....
[8] MolMed S.p.A.. (3/7/19). "Press Release: MolMed and Genenta Science Confirm and Extend Their Partnership in the Oncology field". Milan....
[9] MolMed S.p.A.. (9/11/18). "Press Release: MolMed Appoints Mr. Salvatore Calabrese Chief Financial Officer". Milan....
[10] MolMed S.p.A.. (7/13/18). "Press Release: MolMed Signs a New, Three-year Agreement for the Development and Supply of Lentiviral Vectors. MolMed Will Provide GSK with Vectors for the Oncology Field". Milan....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]